Vascularity

MTF Biologics Awards 2022 Extramural Research Grants

Retrieved on: 
Wednesday, January 11, 2023
Health, Other Health, Other Science, General Health, Research, Science, Spine, University, Intellectual property, Face, MTF, COVID-19, Doctor of Philosophy, Hand, EVP, Cedars-Sinai Medical Center, Proposal, Sports medicine, Elective surgery, Research, Letter, RESEARCH, MRI, Vascularity, Transplant, Immunomodulation, Request for proposal, Request, Health, Pharmaceutical industry, Medical imaging

MTF Biologics , a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program .

Key Points: 
  • MTF Biologics , a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program .
  • “We are so pleased that, even in the face of global economic uncertainty and ongoing challenges associated with the COVID-19 pandemic, MTF Biologics is able to continue giving back to the scientific and patient community through our Extramural Research Grants Program,” said Joe Yaccarino, president and CEO of MTF Biologics.
  • It is our hope that these studies will provide novel allograft-based options for a variety of clinical conditions.”
    2022 MTF Biologics Research Grants were awarded to the following:
    MTF BIOLOGICS EXTRAMURAL RESEARCH GRANT – ESTABLISHED INVESTIGATOR:
    MTF BIOLOGICS EXTRAMURAL RESEARCH GRANT– JUNIOR INVESTIGATOR:
    Mark Haber, M.D., Southern Orthopedics (Australia) “Allograft Augmentation of Irreparable Supraspinatus Tendon Tears: An Evaluation of Graft Healing Rate and Vascularity with Ultrasound And MRI, And Clinical Outcomes”)
    Meghan McCullough, M.D., Cedars Sinai Hospital “Use of allograft adipose matrix for small joint arthritis of the hand.
  • “We received many high quality grant proposals this year,” said Jeffrey Cartmell, Ph.D., director, Intellectual Property & Grants at MTF Biologics.